Regenerative Medical Solutions is a developer of regenerative medical products used to treat diabetes. The company offers ProgenMix, a media formulation that generates pancreatic progenitor cells and endocrine cell types; works with multiple human ESC and iPSC lines; and operates as a platform for drug testing and assay development. It also provides consulting services; and engages in developing treatments and applications for diabetes patients. The company’s ProgenMix is used in various applications ranging from scientific research to testing the potential toxicity of candidate drugs.